Mitchell, J., Camacho, N., Shea, P., Stopsack, K. H., Joseph, V., Burren, O. S., Dhindsa, R. S., Nag, A., Berchuck, J. E., O’Neill, A., Abbasi, A., Zoghbi, A. W., Alegre-Díaz, J., Kuri-Morales, P., Berumen, J., Tapia-Conyer, R., Emberson, J., Torres, J. M., Collins, R., Wang, Q., Goldstein, D., Matakidou, A., Haefliger, C., Anderson-Dring, L., March, R., Jobanputra, V., Dougherty, B., Carss, K., Petrovski, S., Kantoff, P. W., Offit, K., Mucci, L. A., Pomerantz, M., Fabre, M. A. (2025). Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. Nature Communications. https://doi.org/10.1038/s41467-025-56944-1